Innovations in Cancer Control Grants Expression of Interest Guidelines

Innovations in Cancer Control Grants 2018-2019 Expression of Interest Guidelines CLOSING DATE FOR SUBMISSIONS: Midnight, 25 March 2018 Version 1.0 12 December 2017

Table of Contents INTRODUCTION...3 OBJECTIVES OF THE PROGRAM...3 ELIGIBILITY CRITERIA - TO BE ELIGIBLE FOR FUNDING IN 2018-2019:...3 OUT OF SCOPE THE FOLLOWING ITEMS ARE OUT OF SCOPE FOR THIS GRANT ROUND:...4 PRIORITY AREAS SUMMARY...5 PRIORITY AREAS 2018-2019...6 PRIORITY 1: ABORIGINAL COMMUNITY ENGAGEMENT...6 Essential Criteria:...6 Desirable Criteria:...6 PRIORITY 2: BOWEL CANCER SCREENING - IMPROVING ACCESS TO PUBLIC COLONOSCOPY SERVICES WITHIN NSW LOCAL HEALTH DISTRICTS...7 Essential Criteria:...7 Desirable Criteria:...8 Out of Scope:...8 PRIORITY 3: BOWEL CANCER SCREENING - MULTICULTURAL COMMUNITY ENGAGEMENT...9 Essential Criteria:...9 Desirable Criteria:... 10 Out of Scope:... 10 PRIORITY 4: BUILDING ON INNOVATIONS IN CANCER CARE... 11 Essential Criteria:... 11 Desirable Criteria:... 12 Out of Scope:... 12 PRIORITY 5: CERVICAL SCREENING PROGRAM: IMPROVING SCREENING PARTICIPATION RATES AMONG NEVER AND UNDER-SCREENERS... 13 Essential Criteria:... 14 Desirable Criteria... 14 PRIORITY 6: IMPROVING THE EXPERIENCES OF PEOPLE WITH CANCER IN MULTICULTURAL COMMUNITIES. 15 Essential Criteria:... 15 Desirable Criteria:... 16 PRIORITY 7: INVESTIGATING UNWARRANTED CLINICAL VARIATION AND ADDRESSING UNWARRANTED CLINICAL VARIATION... 17 Essential Criteria... 18 Desirable Criteria... 18 PRIORITY 8: TOBACCO CONTROL - SOCIAL MARKETING GRANTS... 179 Essential Criteria... 20 Desirable Criteria:... 21 TIMELINE..22 FUNDING... 22 EXPRESSION OF INTEREST EVALUATION... 23 SUBMITTING AN EXPRESSION OF INTEREST... 24 2

Introduction The Cancer Institute NSW (the Institute) is Australia s first state-wide governmentsupported cancer control agency. Our vision is to lessen the impact of cancer in NSW and we are focused on taking a collaborative approach to improving outcomes in cancer prevention, diagnosis, treatment, care and ultimately, survival. The Institute is working on delivering the NSW Cancer Plan, the NSW Government strategy that sets the platform for programs and campaigns aimed at lessening the impact of cancer across NSW. The NSW Cancer Plan can be downloaded from the Institute s website: www.cancerinstitute.org.au. The 2016-2020 NSW Cancer Plan continues to build upon the 2011-2015 NSW Cancer Plan with a focused attention on priority populations and priority cancers to both improve cancer outcomes and lessen inequity within the community. Objectives of the Program The Innovations in Cancer Control Grant Program aims to provide funding to organisations working in cancer, health and other related services with an interest in cancer control, to undertake evidence-based projects that have the potential to be embedded in the health system and be sustainable past the funding period. The focus of these grants is service-centred initiatives and not research proposals. Consideration will be given to applications which: Assist health care professionals transfer research outcomes into clinical practice; Build upon evidence which is currently available (e.g. publications, previous initiatives/projects); Enhance community engagement or cancer service provision by working towards the goals of the NSW Cancer Plan; Target the priority populations and/or cancers of the NSW Cancer Plan. Eligibility Criteria - To be eligible for funding in 2018-2019: 1. The organisation must be a registered organisation/company with a demonstrated interest in cancer control or vested interest in improving cancer outcomes for specific groups in the community and be based in and providing services to the population of NSW. 3

2. There are eight priority areas in the Innovations in Cancer Control Grants 2018/19. Applicants must apply using the attached Expression of Interest response template, submitting a separate application for each project if applying for more than one grant. 3. The project must commence in the 2018-2019 financial year and be completed at the latest by 30 June 2020. 4. All obligations regarding previously funded grant projects involving the applicant must have been fulfilled to the satisfaction of the Cancer Institute NSW. Such obligations include the provision of satisfactory progress, final and financial reports. 5. The project must have an evaluation approach that includes process and outcome measures. It is recommended that up to 10% of the total project cost is allocated to evaluation (a template will be provided to successful applicants). Out of Scope 1 the following items are out of scope for this grant round: 1. Capital purchases. 2. Funding for research proposals. 3. The continuation and/or evaluation of existing programs/initiatives. 4. Funding for clinical service positions or the delivery of clinical services. Please note, the funding may be used to appoint a fixed term project officer, or similar position to undertake the project. 1 Note: Individual priority areas might have additional out of scope items, please check the relevant section in this document. 4

Priority Areas Summary # Priority Area Available Funding (excluding GST) 1 Aboriginal Community Engagement up to a maximum value of $120,000 per grant 2 Bowel Cancer Screening: Improving access to public colonoscopy services within NSW Local Health Districts 3 Bowel Cancer Screening: Multicultural Community Engagement 4 Building on Innovations in Cancer Care 5 Cervical Screening Program: Improving screening participation rates among never and underscreeners 6 Improving the Experiences of People with Cancer in Multicultural Communities 7 Investigating clinical variation and addressing unwarranted clinical variation 8 Tobacco Control: Social Marketing Grants up to a maximum value of $90,000 per grant, per year up to a maximum value of $10,000 per grant up to maximum value of $120,000 per grant up to a maximum value of $100,000 per grant, per year up to maximum value of $120,000 per grant up to a maximum of $100,000 per grant A minimum value of $100,000 and a maximum value of $200,000 per grant, per year Eligible Agencies Length of Grant Page LHD, PHN, ACCHS up to 24 months 6 LHD, St Vincent s Health Network, Justice Health, Forensic Mental Health LHD, PHN, NGO, community organisation min 12 max 24 months 7 up to 12 months 9 LHD, PHN up to 24 months 11 LHD, PHN, NGO, University, community organisation up to 24 months 13 LHD, PHN, NGO up to 24 months 15 LHD Government organisation, community organisation, NGO Min 12 max up 24 months min 18 max 24 months 17 19 5

Priority Areas 2018-2019 Priority 1: Aboriginal Community Engagement Up to a maximum value of $120,000 per grant excluding GST, up to 24 months. It is acknowledged that community engagement is essential if the burden of cancer on Aboriginal Communities in NSW is to be reduced. The purpose of these grants is to develop, implement, and evaluate innovative strategies which aim to build health literacy through partnerships, whilst supporting and facilitating equitable access to cancer services for Aboriginal people and communities with cancer, or improve cancer service delivery aligned to the goals of the NSW Cancer Plan, and the key principles outlined in the National Aboriginal & Torres Strait Islander Cancer Framework 2015. These grants also aim to build health literacy, develop organisational partnerships and to further support Aboriginal people with cancer in culturally appropriate ways. Essential Criteria: 1. The organisation must be based in NSW and have a demonstrated interest and experience in cancer and Aboriginal Health. 2. The project aligns with the NSW Cancer Plan, and the principles outlined within the National Aboriginal & Torres Strait Islander Cancer Framework 2015. 3. The project must address one or more of the following focus areas: a. Build sustainable partnerships between Local Health Districts (LHDs), Primary Health Networks (PHNs) and Aboriginal Community Controlled Health Services (ACCHS) to support Aboriginal people with cancer b. Support Aboriginal cancer workforce development c. Build health literacy about cancer in Aboriginal communities and support Aboriginal people affected by cancer to access appropriate services. Desirable Criteria: 1. The project develops or utilises systems to share knowledge, expertise or experience (e.g. communities of practice, information technology). 2. The project has academic partners such as members of a Translational Cancer Research Centre (TCRC) or academics with subject matter expertise. 3. The project focuses on the priority cancers of the NSW Cancer Plan. 4. The project attracts in-kind resources to maximise efficient use of grants funding. 5. The project has the potential for implementation across NSW. 6

Priority 2: Bowel Cancer Screening - Improving access to public colonoscopy services within NSW Local Health Districts Up to a maximum value of $90,000 per grant per year excluding GST, minimum 12 to maximum 24 months. The purpose of this grant is to support the timely diagnosis of bowel cancer by improving access to public colonoscopy services through the development of a direct access model for colonoscopy for patients following a positive FOBT and symptomatic patients identified by other mechanisms. The project must focus on developing a localised, sustainable and economically viable model for direct access colonoscopy services following a positive FOBT with a key performance indicator being improved waiting times. Applicants seeking to build on previous direct access colonoscopy projects to extend into colonoscopy redesign and/or optimal care pathways should consider applying for Priority 4: Building on Innovations in Cancer Care (see page 11). Essential Criteria: 1. The organisation must be a NSW Local Health District (LHD), St Vincent s Health Network, Justice Health and Forensic Mental Health, or a Primary Health Network (PHN) in collaboration with a LHD that provides public colonoscopy services at one or more facilities. 2. The organisation must collaborate with local PHNs, or other relevant agencies in the development of a localised direct access colonoscopy model, demonstrated through letters of support from relevant and engaged collaborative agencies or departments. 3. Agreement to publish the project on the Agency for Clinical Innovation (ACI) Innovation Exchange website. 4. Agreement to participate in the Cancer Institute NSW colonoscopy redesign community of practice, a forum for the exchange of knowledge and information on colonoscopy redesign projects. Attendance and presentation of the grant project at two face-to-face workshops will be required. 5. The project application must demonstrate sustainability of the initiative; e.g. how the project will continue to contribute to achieve NSW Cancer Plan goals beyond the funding period of the grant. 7

Desirable Criteria: 1. Projects that improve colonoscopy services for all positive FOBT screened patients, not just those screened as part of the NBCSP e.g. patients screened using GP, Rotary or Pharmacy purchased FOBTs. 2. Provision of services to higher risk populations such as Culturally and Linguistically Diverse (CALD), Aboriginal, rural and remote or socioeconomically disadvantaged. 3. Implementation of the project across multiple facilities /sites within the LHD/PHN. 4. The project has academic partners such as members of a Translational Cancer Research Centre (TCRC) or academics with subject matter expertise. 5. The project attracts in-kind resources to maximise efficient use of grants funding. 6. Projects that look at alternative workforce solutions to provide colonoscopy services such as, for example, a nurse provider model. Out of Scope: 1. Creation of extra colonoscopy lists or adding to existing colonoscopy lists. 8

Priority 3: Bowel Cancer Screening - Multicultural Community Engagement Up to a maximum value of $10,000 per grant, excluding GST, up to 12 months. The objective of this grant is to engage NSW multicultural organisations in the delivery of Culturally and Linguistically Diverse (CALD) community education on bowel cancer and bowel screening to CALD communities, ultimately addressing barriers to screening and improving participation in the National Bowel Cancer Screening Program. People from CALD backgrounds have been identified as a priority population by the Cancer Institute NSW Bowel Cancer Screening Program. In Australia, people from non- English speaking backgrounds have significantly lower rates of bowel cancer screening participation, estimated at 27% compared to 40% in the English-speaking background population. Research and findings of previous community engagement work, has shown that for people from CALD groups, endorsement and support from a health or other trusted organisation, or professional, may help address several identified barriers to screening: including language barriers, low levels of health and cancer literacy, problems with selfefficacy and confidence in completing the test kit, lack of understanding regarding the purposes of screening (particularly in the absence of symptoms), fatalistic views about cancer and embarrassment. The use of existing National Bowel Cancer Screening Program and Cancer Institute NSW resources will be encouraged. The Cancer Institute NSW is planning the development of educational support resources which should be used where possible to deliver education sessions. Grant recipients will be invited to nominate a facilitator/staff member to attend training at the Institute about how to use these resources. Essential Criteria: 1. The organisation must be a Local Health District (LHD), Primary Health Network (PHN), non-government organisation (NGO) or community organisation based in NSW with an interest in public health. 2. The focus of the grant project must be on men and/or women in NSW, 50-74 years of age, from CALD communities with clear justification for why the CALD community, or communities, have been chosen. 3. The project must involve activities that improve the grant recipient s organisational capability to talk to clients about bowel cancer and bowel cancer screening (i.e. staff training). 9

4. The project must involve facilitating culturally-tailored health screening education sessions or workshops and/or community events to promote bowel cancer screening amongst people from CALD communities (aged 50-74). 5. Demonstrated allocation of appropriate staffing/resourcing to project management, training and facilitation (for both staff and community focused education sessions and /or events). 6. Commitment to working closely with the Institute to develop the project methodology and messaging, and participating in workshops hosted by the Institute to share learnings from the grant project with other grant recipients and interested stakeholders. 7. Following community engagement activities, brief identification of key learnings and potential recommendations for the development of future strategies to improve bowel cancer screening participation of the specific CALD community must be submitted in the final report (and potentially through a presentation). Desirable Criteria: 1. The grants are particularly suited to multicultural health or community services organisations and units (state-wide or regional) that are involved in the direct provision of education, information and support to their communities. 2. Demonstrated previous experience in delivering health messages or community consultation projects. 3. The initiative targets a maximum of two language groups. 4. The initiative focuses on CALD communities that reside in regions that have been identified as priority areas, based on low bowel cancer screening participation rates, specifically Western Sydney, South Western Sydney and Central and Eastern Sydney Primary Health Network (PHN) regions. 5. The initiative utilises relationships with key stakeholder organisations and partners (such as the Multicultural Health Communication Service, PHNs, LHDs or other key stakeholders and influencers within the CALD communities). 6. Focus on sustainable and transferable initiatives that can be embedded within the grant recipient organisation. Out of Scope: 1. The project cannot involve the distribution of bowel cancer screening kits for completion by participants. 10

Priority 4: Building on Innovations in Cancer Care Up to a maximum value of $120,000 per grant, up to 24 months, excluding GST. The purpose of these grants is to support, implement, and evaluate innovative strategies and localised pathways which aim to support and facilitate equitable access to cancer services for people and communities with cancer or improve cancer service delivery aligned to the goals of the NSW Cancer Plan. It also aims to conceptualise and improve the resources available to support, promote and improve the survival of people with cancer. This category can include the implementation and localisation of optimal care pathways with the use of the methodology in the Cancer Care Pathways Toolkit, developed in partnership with the Cancer System Innovation Managers Community of Practice. Essential Criteria: 2. The lead applicant is a NSW Local Health District (LHD) or Primary Health Network (PHN). 3. The project aligns with the LHD/PHN strategic plan or local Cancer Plan and the NSW Cancer Plan. 4. Addresses a specific problem or issue identified locally that has potential to impact on cancer services and outcomes for people affected by cancer. 5. Involves collaboration with local people affected by cancer as members of the project team as either Consumer Advisors and/or project partners. 6. The project aims to address one of the categories below: a. Building automated processes to enhance data collection as part of multidisciplinary cancer care. b. Localisation of Optimal Care Pathways, prioritising lung, bowel and liver as a prerequisite prior to other tumour types. c. Building on systems and processes to improve psycho-oncology care. d. Other innovative projects that impact cancer service provision for people with cancer and their families and carers. 7. The project application must demonstrate sustainability of the initiatives; e.g. how the project will continue to contribute to achieve its goals beyond the funding period of the grant. 11

Desirable Criteria: 1. The project encourages collaboration (LHDs, PHNs, non-government organisations) to maximise efficient use of grant funding to achieve a common goal. 2. The project has academic partners such as members of a Translational Cancer Research Centre (TCRC) or academics with subject matter expertise. 3. The project develops or utilises systems to share knowledge, expertise or experience (e.g. communities of practice, information technology). 4. The project focuses on the priority cancers of the NSW Cancer Plan. 5. The project attracts in-kind resources to maximise efficient use of grants funding. 6. The project has the potential for implementation across NSW. Out of Scope: 1. Applicants who have previously received funding for the development of a localised pathway are not eligible for further funding to define, localise or improve the same pathway. 12

Priority 5: Cervical Screening Program: Improving screening participation rates among never and under-screeners Up to a maximum value of $100,000 per grant, per year, excluding GST, up to 24 months. On 1 December 2017 a renewed National Cervical Screening Program (NCSP) was implemented, which has changed the way cervical screening is implemented and performed. Women aged 25-74 are invited to have a Cervical Screening Test every five years. The Cervical Screening Test detects oncogenic types of Human Papillomavirus (HPV) which is the virus that causes most cervical cancers. A new National Cancer Screening Register (NCSR) was set up to support the renewed NCSP. Embedding the renewed NCSP in order that health professionals understand the changes and women understand the changes and subsequently participate in screening in a timely fashion is a challenge, especially among priority groups where levels of never screening or under-screening are high. The objectives of these grants are to: 1. Develop innovative strategies to increase cervical screening participation within a targeted population group. 2. Increase participation rates among priority populations. 3. Develop recommendations for broader implementation and sustainability. Target populations for this grant have participation rates which are lower than average, and include but are not limited to: - women from Culturally and Linguistically Diverse (CALD) communities - women with disabilities - Aboriginal and Torres Strait Islander women - women in rural and remote areas - women in areas of high social disadvantage - young women (aged 25-34 years) - women who have experienced sexual or physical abuse - women from refugee communities - lesbian, bisexual, transgender, intersex, queer (LBTIQ) people An application may reach more than one priority group. The grant application must address the needs of each priority group that the proposed project will reach. 13

Essential Criteria: 1. The organisation must be a non-government organisation (NGO), community organisation, Local Health District (LHD) or Primary Health Network (PHN), based in NSW with an interest in public health. 2. Provision of a clear rationale for the proposed project initiative and how it will improve cervical screening participation amongst the target population of women aged 25 to 74 years. (Initiatives that focus on specific cohorts within the target population will be considered e.g. specific ages or geographies). 3. The initiative must be a multi-pronged strategy aimed at improving awareness and behaviour, and be an integrated approach which engages both the local community and cervical screening service providers. 4. Alignment of project initiatives with the NSW Cancer Plan, National Cervical Screening Program and any other strategic frameworks relevant to the chosen target population. 5. Commitment to work with the NSW Cervical Screening Program around messaging to ensure alignment with NCSP policy. 6. Inclusion of an evaluation approach in the application that includes methodology, process and outcome measures to demonstrate the grant s impact on cervical screening participation within the target population, and potential cost effectiveness (See Desirable Criteria 1). 7. The application must demonstrate sustainability of the initiatives; e.g. how the project will continue to contribute to achieve NSW Cancer Plan goals beyond the funding period of the grant. 8. Resources and/or strategies developed within the grant may be used by the NSW Cervical Screening Program, shared with other organisations and/or listed on the Institute s website. Desirable Criteria 1. Collaboration with an academic institution or other research agency to plan and conduct evaluation of the initiative. 2. The project attracts in-kind resources to maximise efficient use of grants funding. 14

Priority 6: Improving the Experiences of People with Cancer in Multicultural Communities Up to a maximum value of $120,000 per grant, excluding GST, up to 24 months. Evidence indicates that multicultural communities have higher incidence of cancer and may experience poorer cancer outcomes. Also, certain groups within the multicultural communities are at risk of specific cancers. To address these equity issues the Cancer Institute NSW (the Institute) has adopted a multicultural equity framework focusing on four strategic areas: 1. Collecting evidence of multicultural equity issues relevant to goals of the NSW Cancer Plan. 2. Engaging with multicultural communities in developing and delivering NSW Cancer Plan initiatives. 3. Ensuring multicultural equity by filling gaps and further embedding culturally appropriate strategies and activities within NSW Cancer Plan initiatives. 4. Taking leadership in multicultural equity through innovation and by setting best practice benchmarks. The grants available are to aid in the planning, development, implementation, and evaluation of programs (within the scope of the NSW Cancer Plan) which aim to address the equity issues of multicultural communities, and thereby improve the survival rates of patients with cancer from multicultural backgrounds. Essential Criteria: 1. The lead applicant must be a NSW Local Health District (LHD), non-government organisation (NGO), or Primary Health Network (PHN). If the lead applicant is an NGO, the organisation must demonstrate significant experience in delivering health programs and/or must partner with appropriately skilled and experienced organisations and provide evidence of such. 2. The project must address: a. Issues experienced by people affected by cancer in multicultural communities. b. A prioritised action of the NSW Cancer Plan. c. At least one of the four strategic areas of the Multicultural Equity Framework of the Institute. 15

3. The application must demonstrate sustainability of the initiative; e.g. how the project will continue to contribute to achieving NSW Cancer Plan goals beyond the funding period of the grant. Desirable Criteria: 1. The project aligns with the LHD/organisation strategic plan or local Cancer Plan. 2. The project encourages collaboration with eligible agencies (LHDs, PHNs, NGOs) to maximise efficient use of grants funding to achieve a common goal. 3. The project has academic partners such as members of a Translational Cancer Research Centre (TCRC) or academics with subject matter expertise. 4. The project attracts in-kind resources to maximise efficient use of grant funding. 5. The project develops or utilises systems to share knowledge, expertise or experience (e.g. communities of practice, information technology). 6. The project has the potential for implementation across NSW. 16

Priority 7: Investigating unwarranted clinical variation and addressing unwarranted clinical variation Up to a maximum value of $100,000 per grant excluding GST, minimum 12 to maximum 24 months. The purpose of this grant is to support the investigation of clinical variation in care for one of the specified cancer types (see essential criteria), and development of a continuous quality improvement strategy to address unwarranted variation or improve quality of systems and care; ultimately improving cancer service delivery aligned to the goals of the NSW Cancer Plan. The NSW Cancer Plan aims to increase the survival of people with cancer through improving cancer outcomes. This goal and objective will be met through strengthening the capacity of the cancer system to deliver high quality, patient centred, integrated, multidisciplinary care, with a focus on reducing unwarranted clinical variation. Clinical variation currently exists in cancer care between Local Health Districts (LHDs), individual hospitals and other settings. Some variation in health care is warranted, for example when variation can be explained by differences in health status or patient preferences. However, variation that cannot be explained by patient needs and preferences is classified as unwarranted variation. If unaddressed, it has the potential to reduce safety, quality, patient experience, performance effectiveness and efficiency outcomes. As part of the Cancer Institute NSW s Reporting for Better Cancer Outcomes (RBCO) program, data on key measures of cancer treatment quality are benchmarked by LHDs, hospitals, or facilities. The RBCO program and local data have the potential to highlight clinical variation, and can; 1. provide a signal for when further work is required to determine if the clinical variation is unwarranted or 2. identify when there is potential to improve quality of systems and care provision The grants available can be used towards: Conducting clinical audits Data collection (qualitative and/ or quantitative) Data analyses (e.g. statistical) Education & training Service redesign and evaluation 17

Clinician forums/ workshops Essential Criteria 1. The organisation must be a NSW Local Health District (LHD). 2. The submission must address one of the following cancer focus areas: a) Lung cancer b) Rectal cancer c) Bladder cancer d) Oesophageal and gastric cancer e) Pancreatic and primary liver cancer, cholangiocarcinoma. 3. The project identifies clinical leadership with subject-matter expertise and a governance structure that includes input by and feedback to clinicians. 4. Provision of a clear rationale for the proposed project initiative, including outlining what clinical variation has been identified (provide data) and how clinical variation will be investigated. 5. Provide a draft and/ or governance structure to outline how any identified unwarranted variation will be addressed. 6. Provide an outline for how identified opportunities to improve quality of systems and care will be approached; particularly when variation is not found to be unwarranted however, opportunities for system change are identified. 7. Commitment to working closely with the Institute to develop a statewide framework to understanding clinical variation and addressing unwarranted clinical variation. Desirable Criteria: 1. The project aligns with the LHDs strategic plan or local Cancer Plan. 2. The project encourages collaboration with eligible agencies (LHDs, PHNs, NGOs) to maximise efficient use of grants funding to achieve a common goal. 3. The project attracts in-kind resources to maximise efficient use of grant funding. 4. The project develops or utilises systems to share knowledge, expertise or experience (e.g. communities of practice, information technology). 5. The project has the potential for implementation across NSW. 6. The project has academic partners such as members of a Translational Cancer Research Centre (TCRC) or academics with subject matter expertise. 18

Priority 8: Tobacco Control - Social Marketing Grants To the value of minimum $100,000 to maximum $200,000, per grant per year, excluding GST, up to 24 months. The Social Marketing Grants offer funding to community and government/nongovernment incorporated organisations in NSW to undertake evidence-based communication activities that support the wider goals of the Cancer Institute NSW (the Institute) tobacco control program; and specifically, to address tobacco related harm and reduce smoking prevalence rates in Aboriginal and Culturally and Linguistically Diverse (CALD) communities. An objective of the NSW Cancer Plan is to reduce the use of tobacco and tobacco products, and identified priority populations in the NSW Cancer Plan and NSW Tobacco Strategy including Aboriginal and CALD communities. The 2016 NSW Adult Population Health Survey estimates that 39.7% of Aboriginal adults smoke compared to 14.4% of non - Aboriginal adults. The 2009 NSW Adult Population Health Survey estimated smoking rates of 34%, 32% and 20% respectively for Arabic (Lebanese), Chinese (males only) and Vietnamese (males only) adults compared with 15% for the general adult population. The grant program is aligned with the NSW Cancer Plan, the NSW Tobacco Strategy, the Strategic Framework for Aboriginal Tobacco Resistance and Control (ATRAC) in NSW, and the key principles outlined within the National Aboriginal & Torres Strait Islander Cancer Framework 2015. The focus of these grants is the delivery of culturally appropriate communication activities. The grants must deliver communication activities with multicultural and Aboriginal audiences via a communication strategy. The communication activities to be delivered through the grant program will also align with the Government Advertising Guidelines, and will be prepared in accordance with the Government Advertising Act 2011. The proposed projects must specifically focus on the following: 1. The communication activities delivered can take the form of media or non-media communications (non-media communications may include events, participation at cultural festivals, direct mail, competitions and websites). 19

2. The communication activities delivered must support the objectives of the Institute s annual campaign program: a. To contribute to a decline in smoking prevalence in NSW b. To contribute to an increase in NSW smokers intentions to quit c. To contribute to an increase in those who have never smoked in NSW d. To encourage the use of quit support services, specifically: NSW Quitline (including multilingual and Aboriginal) and/ or icanquit.com.au 3. The approach to both media and non-media activities should be informed by research and evidence. Essential Criteria 1. The submission must address one of the following focus areas: a. Development, implementation and evaluation of a communication strategy targeting Aboriginal smokers. b. Development, implementation and evaluation of a communication strategy targeting smokers from CALD Communities (Arabic, Chinese and Vietnamese speaking communities will be prioritised due to their high smoking rates). 2. Development and implementation of proposed projects must be underpinned by strong engagement with relevant communities. 3. Proposed projects must be multi-faceted and include a number of interlocking initiatives (e.g. public relations, development of communication materials, engagement of community leaders, community events etc.). 4. Development and delivery of relevant communication materials that: a. raise awareness of the harms of tobacco smoking in a culturally appropriate way; and/ or b. encourage the use of quit support services, specifically: NSW Quitline (including multilingual and Aboriginal services) and/ or icanquit.com.au Communication materials can be delivered via paid or non-paid media and/or community engagement activities. 5. A minimum of six months of communication activities must occur in both the 2018/19 and 2019/20 financial years. 6. Partnership with or contracting of a communications agency or demonstrable communications expertise internally. 7. Proposed projects should include promotion or support for the use of Aboriginal or Multilingual Quitline services. 8. Collaborate or partner with other relevant stakeholder organisations/groups. 20

9. Demonstrate alignment with tobacco control strategic frameworks (i.e. NSW Tobacco Strategy and the NSW Cancer Plan), ATRAC and the key principles outlined within the National Aboriginal & Torres Strait Islander Cancer Framework 2015. 10. The planned evaluation approach must be embedded in the project design, with particular focus on clear and demonstrated behaviour change outcomes and the potential scalability or sustainability of the initiative. 11. Successful grant recipients are required to work in collaboration with similar grantees/projects to improve project outcomes and minimise duplication of resources through a community of practice which will be facilitated by the Institute. Desirable Criteria 1. Collaboration with an academic institution or other research agency to plan and conduct evaluation of the initiative. 2. In-kind support provided by the lead or partner organisations. 21

Timeline Key dates for the Innovations in Cancer Control Grants 30 January 2018 February 2018 Call for Expressions of Interest Grant information forums 25 March 2018 March April 2018 Close of applications Finalise review of applications May 2018 2 July 2018 July August Regularly throughout the grant 30 June 2020 (or earlier as applicable) Notification to applicants Funding provided and projects commence (including the provision of a detailed project plan) Commencement meeting between Cancer Institute NSW and grant recipients Project progress reporting Final report/project closure Funding The funds must be spent for the primary purpose of achieving the objectives of the Innovations in Cancer Control grants. All projects funded under the program will be required to report against evaluation measures developed by the applicants as part of the submission process. Funding is available for registered organisations/companies in NSW. If a joint application is received and successful, funding will be provided to the lead applicant and distribution of funds is their ultimate responsibility. This should be identified in the project budget to be submitted as part of the Expression of Interest. The Cancer Institute NSW reserves the right to award funds at a different level and for varying periods to that requested in the Expression of Interest. As part of the final reporting requirements, a full financial acquittal verified by a certified officer is required. 22

Funding is not to be used for clinical service positions or provision of clinical services. Funding should be used to support the establishment of sustainable models of care/initiatives that can continue beyond the funding period. Please note that funding may be used to appoint a temporary Project Officer, or similar position to undertake the project. There is an expectation that successful applicants will participate in a relevant Communities of Practice group and submit an abstract to the Cancer Institute NSW Innovations in Cancer Treatment and Care Conference (or other agreed conference). Expression of Interest Evaluation Upon receipt, applications will be reviewed for completeness and adherence to submission requirements. Successful applicants will be selected through a competitive process. Each Expression of Interest will be reviewed and scored according to the project concept including: sustainability project methodology expected outcomes and proposed evaluation approach project budget experience/background of organisation focus and current activities of the organisation. The evaluation criteria listed above should be addressed throughout the Expression of Interest and will be considered and scored as part of the selection process. Applicants may be asked to provide additional information in order for the panel to reach a final decision. Each Chief Executive/Chief Executive Officer, Project Sponsor, Head of Department (or equivalent) and Project Lead detailed in the Expression of Interest will be notified in writing of the evaluation outcome. The Cancer Institute NSW is unable to provide any additional information about the reasons for being successful/unsuccessful beyond what is stated in the letter of notification. 23

Submitting an Expression of Interest The Expression of Interest template must be used to complete your application. Expressions of Interest should provide all requested information. Only information provided in the Expression of Interest will form the basis of the review process. Expressions of Interest should not exceed 10 pages plus 4 pages of supporting documentation. In completing the Expression of Interest template delete the red instructional text. Documentation including a signed cover letter from the Chief Executive endorsing the application and providing their support/sponsorship is to be provided. Completed proposals should be marked CONFIDENTIAL. Applications must be received at the Cancer Institute NSW by midnight, 25 March 2018. Incomplete or late submissions will not be accepted. Please email submission to innovations@cancerinstitute.org.au with Innovations in Cancer Control Grants Application and the name and number of the priority area, in the e-mail subject line, or post to Innovations in Cancer Control, Cancer Institute NSW, PO Box 41, Alexandria NSW 1435. If you would like to discuss your Expression of Interest, please email the Cancer Institute NSW at innovations@cancerinstitute.org.au. Please include the priority area you are wishing to discuss so your enquiry can be allocated appropriately. The Cancer Institute NSW will also be holding information forums for some of the priority areas. Dates and times for these forums along with the and Response Template are available on the Cancer Institute NSW website http://www.cancerinstitute.org.au 24